Scott Rottinghaus
Chief Tech/Sci/R&D Officer presso ENANTA PHARMACEUTICALS, INC.
Patrimonio netto: 493 891 $ in data 31/03/2024
Posizioni attive di Scott Rottinghaus
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 08/08/2022 | - |
Storia della carriera di Scott Rottinghaus
Precedenti posizioni note di Scott Rottinghaus
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Formazione di Scott Rottinghaus
| University of Cambridge | Graduate Degree |
| Kansas State University | Undergraduate Degree |
| Mayo Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 2 |
| 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Scott Rottinghaus
- Esperienza
